Financial statements Biotechnology Consulting And Investment

Balance sheet of Biotechnology Consulting And Investment

Company age:
Age:
11 y. 10 m. 26 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOTECHNOLOGY CONSULTING AND INVESTMENT

Year
2019
2020
2021
2022
2023
Total assets 1 576 257,24 6 398,58 1 574 637,38 1 569 919,88 1 566 642,47
A. Fixed assets 735 000,04 0,00 0,00 0,00 0,00
B. Current assets 841 257,20 1 579 155,82 1 574 637,38 1 569 919,88 1 566 642,47
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 576 257,24 1 579 155,82 1 574 637,38 1 569 919,88 1 566 642,47
A. Equity 625 869,93 623 795,88 624 076,64 619 509,51 616 373,10
B. Liabilities and provisions for liabilities 950 387,31 955 359,94 950 560,74 950 410,37 950 269,37
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 950 387,31 955 359,94 950 560,74 950 410,37 950 269,37
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.